dc.contributorManrique Hernández, Rubén Darío
dc.creatorMoscote Rivera, Maria Isabel
dc.creatorPérez Carreño, Juan Guillermo
dc.creatorGutiérrez Pinzón, Vivian Patricia
dc.date.accessioned2019-10-25T15:44:04Z
dc.date.accessioned2022-09-22T14:07:16Z
dc.date.available2019-10-25T15:44:04Z
dc.date.available2022-09-22T14:07:16Z
dc.date.created2019-10-25T15:44:04Z
dc.identifierhttps://repository.urosario.edu.co/handle/10336/20488
dc.identifierhttps://doi.org/10.48713/10336_20488
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3435990
dc.description.abstractIntroduction: Neuromuscular Blockers Agents (NMBA) are routinely used in anaesthesia, although they don´t have anaesthetic properties and adverse events and mortality have been reported. Muscular relaxation is more a result of quality of anaesthesia that a muscular paralysis. Like this, abdominal surgeries are realized under anaesthesia without NMBA. Efforts made to avoid Postoperative Residual Curarization and intraoperative awareness have not diminished their incidence, and risk of use NMBA is not established. Judicious use of NMBA in specific situations may decrease adverse effects and cost of anaesthesia. Objective: Make a comparison of frequency of adverse events on perioperative period of adult patients, who suffer surgical procedures under general anaesthesia, in whose received NMBA with respect those received other techniques without NMBA. Methods: Systematic Review of literature. Eligibility criteria: Clinical trial if were published, observational studies in adults with surgery that reporting adverse events and mortality during perioperative period with use or without NMBAs. Studies on paediatric or obese patient, trauma, obstetric and cardiac surgery were excluded. Search and select Methods: Last fifteen years in PubMed, EMBASE, LILACS, Cochrane, and grey literature, without exclusion languages, seeking with Decs, Mesh, emtree and synonymous. Search strategy was: "Anaesthesia" (P) + "Neuromuscular Blocking Agents" (I) + “Adverse Effects” (O), including synonymous. We will use PRISMA (Preferred Items for Systematic Reviews and Metanalysis) flow chart and checklist. The protocol was registered on PROSPERO with the number CRD42019128550 and only was modified search strategy before beginning. Collect and analysis: Mendeley will be selected as reference manager. Independently, three reviewers seemed, selected and evaluated quality of articles. In disagreement case, a fourth reviewer decided. PRISMA checklist will be used to design of review, Review Manager 5 to analyse cuantitative data. Frequency of adverse events was measured, incidence of residual neuromuscular blockade, relative risk and others according information available and homogeneity of studies. Checklist CONSORT, STROBE, New Castle-Ottawa and risk of bias tool of Cochrane and GRADE System for certainty of evidence. Results: 433 studies were founded after duplicated to be removed. Seven studies were select, and four of them, observational studies with good agreement, methodological and report quality. Metanalysis of four prospective cohort studies were performed, finding an increased risk of postoperative respiratory complications when using NMBA (RR: 2,71 with IC95% 1,99-3,69). Other adverse events of interest could not be evaluated. Conclusions: There is evidence that suggest an increased risk of postoperative respiratory complications when NMBA were used. To establish causality, controlled trials should be performed. There is not enough information about other adverse events.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherMaestría en Epidemiología
dc.publisherMaestría en Actividad Física y Salud
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceBeecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery: based on a study of 599, 548 anesthesias in ten institutions 1948-1952, inclusive. Annals of surgery. 1954;140(1):2-35.
dc.sourceArbous MS, Grobbee DE, van Kleef JW, de Lange JJ, Spoormans H, Touw P, et al. Mortality associated with anaesthesia: a qualatative analysis to identify risk factors. Anaesthesia. 2001;56(February):1141-53.
dc.sourceNaguib M, Magboul MM. Adverse effects of neuromuscular blockers and their antagonists. Middle East journal of anesthesiology. 1998;14(5):341-73.
dc.sourceDonati F. Cost-benefit analysis of neuromuscular blocking agents. Canadian Journal of Anaesthesia. 1994;41(5 II):R3-7.
dc.sourceBrull SJ, Kopman AF. Current Status of Neuromuscular Reversal and Monitoring. Anesthesiology. 2017;126(1):173-90.
dc.sourceBrull SJ, Naguib M, Miller RD. Residual neuromuscular block: Rediscovering the obvious. Anesthesia and Analgesia. 2008;107(1):11-4.
dc.sourceBeny K, Piriou V, Dussart C, Hénaine R, Aulagner G, Armoiry X. Impact du sugammadex sur les consommations de curares: étude pharmaco-épidémiologique multicentrique dans les centres hospitalo-universitaires et hôpitaux d’instructions des armées français. Annales Françaises d’Anesthésie et de Réanimation. 2013;32(12):838-43.
dc.sourceGrosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. Bmj. 2012;345(oct15 5):e6329-e6329.
dc.sourceOrtega A, Sarobe C, Giráldez J, Iribarren MJ. Cost analysis of neuromuscular blocking agents in the operating room: Cisatracurium, atracurium, vecuronium and rocuronium. Pharmacy World and Science. 2000;22(3):82-7.
dc.sourceClaudius C, Garvey LH, Viby-Mogensen J. The undesirable effects of neuromuscular blocking drugs. Anaesthesia. 2009;64(SUPPL. 1):10-21.
dc.sourceKurata J, Hemmings HC. Memory and awareness in anaesthesia. British Journal of Anaesthesia. 2015;115(July):i1-3.
dc.sourceArbous MS, Meursing AEE, van Kleef JW, de Lange JJ, Spoormans HH a JM, Touw P, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology. 2005;102(2):257-68; quiz 491-2.
dc.sourceKollmann-Camaiora A, Alsina E, Domínguez A, del Blanco B, Yepes MJ, Guerrero JL, et al. Protocolo clínico asistencial de manejo de la hipertermia maligna. Revista Espanola de Anestesiologia y Reanimacion. 2017;64(1):32-40.
dc.sourceGrabitz SD, Rajaratnam N, Changani K, Thevathasan T, Teja BJ, Deng H, et al. The Effects of Postoperative Residual Neuromuscular Blockade on Hospital Costs and Intensive Care Unit Admission. Anesthesia & Analgesia. 2019;128(6):1129-36.
dc.sourceBaete S, Vercruysse G, Laenen MV, De Vooght P, Van Melkebeek J, Dylst D, et al. The effect of deep versus moderate neuromuscular block on surgical conditions and postoperative respiratory function in bariatric laparoscopic surgery: A randomized, double blind clinical trial. Anesthesia and Analgesia. 2017;124(5):1469-75.
dc.sourceBronsert MR, Henderson WG, Monk TG, Richman JS, Nguyen JD, Sum-Ping JT, et al. Intermediate-acting nondepolarizing neuromuscular blocking agents and risk of postoperative 30-day morbidity and mortality, and long-term survival. Anesthesia and Analgesia. 2017;124(5):1476-83.
dc.sourceLagasse RS. Anesthesia safety: model or myth? A review of the published literature and analysis of current original data. Anesthesiology. 2002;97(6):1609-17.
dc.sourceWorld Health Organization I. La cirugía segura salva vidas. 2008; Disponible en: http://apps.who.int/iris/bitstream/handle/10665/70083/WHO_IER_PSP_2008.05_spa.pdf?sequence=1
dc.sourceAlkire BC, Raykar NP, Shrime MG, Weiser TG, Bickler SW, Rose JA, et al. Global access to surgical care: A modelling study. The Lancet Global Health. 2015;3(6):e316-23.
dc.sourceWatters DA, Hollands MJ, Gruen RL, Maoate K, Perndt H, McDougall RJ, et al. Perioperative mortality rate (POMR): A global indicator of access to safe surgery and anaesthesia. World Journal of Surgery. 2015;39(4):856-64.
dc.sourceAhiskalioglu A, Ince I, Ahiskalioglu EO, Oral A, Aksoy M, Yiǧiter M, et al. Is Neuromuscular Blocker Necessary in Pediatric Patients Undergoing Laparoscopic Inguinal Hernia Repair with Percutaneous Internal Ring Suturing? European Journal of Pediatric Surgery. 2017;27(3):263-8.
dc.sourceGueret G, Rossignol B, Kiss G, Wargnier JP, Spielman S, Arvieux CC, et al. Is Muscle Relaxant Necessary for Cardiac Surgery? Anesthesia and Analgesia. 2004;99:1330-3.
dc.sourceAmbrogi MC, Fanucchi O, Korasidis S, Davini F, Gemignani R, Guarracino F, et al. Nonintubated thoracoscopic pulmonary nodule resection under spontaneous breathing anesthesia with laryngeal mask. Innovations (Philadelphia, Pa). 2014;9(4):276-80.
dc.sourceKoo B-W, Jung K-W, Oh A-Y, Kim E-Y, Na H-S, Choi E-S, et al. Is neuromuscular blocker needed in children undergoing inguinal herniorrhaphy? Medicine. 2017;96(26):e7259-e7259.
dc.sourceLundström Lars H, Strande S, Müller Ann M, Wetterslev J. Use versus avoidance of neuromuscular blocking agent for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents. Cochrane Database of Systematic Reviews. 2011;Volume|(7).
dc.sourceJain RA, Shetty AN, Oak SP, Wajekar AS, Garasia MB. Effects of avoiding neuromuscular blocking agents during maintenance of anaesthesia on recovery characteristics in patients undergoing craniotomy for supratentorial lesions: A randomised controlled study. Indian Journal of Anaesthesia. 2017;61(1):42-7.
dc.sourceKirmeier E, Eriksson LI, Lewald H, Jonsson Fagerlund M, Hoeft A, Hollmann M, et al. Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. The Lancet Respiratory Medicine. 2018;2600(18):1-12.
dc.sourcePandit J. NAP5: Accidental awareness during general anesthesia in the United Kingdom and Ireland. 2014;(September).
dc.sourceHarper NJN, Cook TM, Garcez T, Farmer L, Floss K, Marinho S, et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). British Journal of Anaesthesia. 2018;121(1):159-71.
dc.sourceSmith CR, Lisa MPH, Simon P, Ma F, Wu J. Canadian physicians ’ knowledge and counseling practices related to antibiotic use and antimicrobial resistance. Canadian Family Physician. 2017;63:e526-35.
dc.sourceSaito S, Mukohara K, Miyata Y. Chronological Changes in Japanese Physicians’ Attitude and Behavior Concerning Relationships with Pharmaceutical Representatives : A Qualitative Study. Plos one. 2014;9(9):1-7.
dc.sourceMurphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesthesia and Analgesia. 2008;107(1):130-7.
dc.sourceDebaene B, Plaud B, Dilly M, Donati F, Ph D. Residual Paralysis in the PACU after a Single Intubating Dose of Nondepolarizing Muscle Relaxant with an intermediate duration of action. Anestehesiology. 2003;98(5):1042-8.
dc.sourceGriffith H, Johnson G. The use of curare in General Anesthesia. Canadian Journal of Anaesthesia. 1942;3:418-20.
dc.sourceThesleff S. The pharmacological properties of succinylcholine iodide; with particular reference to its clinical use as a muscular relaxant. Acta Physiol Scand. 10 de septiembre de 1952;26(2-3):103-29.
dc.sourcePerry JJ, Lee JS, Sillberg VAH, Wells GA. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev. 2008;(2):CD002788.
dc.sourceTran DTT, Newton Ethan K, Mount Victoria AH, Lee Jacques S, Wells George A, Perry Jeffrey J. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database of Systematic Reviews. 2015;(10).
dc.sourceAli HH, Savarese JJ, Embree PB, Basta SJ, Stout RG, Bottros LH, et al. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium. Br J Anaesth. 1988;61(5):541-6.
dc.sourceSiddik-Sayyid SM, Taha SK, Kanazi GE, Chehade J-MA, Zbeidy RA, Al Alami AA, et al. Excellent intubating conditions with remifentanil-propofol and either low-dose rocuronium or succinylcholine. Can J Anaesth. 2009;56(7):483-8.
dc.sourceHerbstritt A, Amarakone K. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: is rocuronium as effective as succinylcholine at facilitating laryngoscopy during rapid sequence intubation? Emerg Med J. 2012;29(3):256-8.
dc.sourceChavan SG, Gangadharan S, Gopakumar AK. Comparison of rocuronium at two different doses and succinylcholine for endotracheal intubation in adult patients for elective surgeries. Saudi J Anaesth. 2016;10(4):379-83.
dc.sourceWierda JM, van den Broek L, Proost JH, Verbaan BW, Hennis PJ. Time course of action and endotracheal intubating conditions of Org 9487, a new short-acting steroidal muscle relaxant; a comparison with succinylcholine. Anesth Analg. 1993;77(3):579-84.
dc.sourceLaszlo G, Chingmuh L, Young-Moon C, Nguyen NT, Tsai SK. Neuromuscular Pharmacology of TAAC3, a New Nondepolarizing Muscle Relaxant with Rapid Onset and Ultrashort Duration of Action. Anesthesia & Analgesia. 2002;94:879-85.
dc.sourceGoswami LN, Olds TJ, Monk TG, Quinn L, Dilger JP, Shanawaz MA, et al. Isomeric Carborane Neuromuscular Blocking Agents. ChedMedChem Chemistry enabling drug discovery. 2019;1-9-.
dc.sourceBasta, S J, Savarese, J J, Ali, Hassan H, Embree, P B. Clinical Pharmacology of Doxacurium Chloride: A New Long-actin Nondepolarizing Muscle Relaxant. Anesthesiology. 1988;69:478-86.
dc.sourceMiguel R, witkowsky T, Hideo N, Fragen R, Bartkowsky R, Foldes F. Evaluation of Neuromuscular and Cardiovascular Effects of Two Doses of Rapacuronium ( ORG 9487 ) versus Mivacurium and Succinylcholine. Anesthesiology. 1999;91:1648-54.
dc.sourceGray C. A Reassesment of the Signs and Levels of Anaesthesia. Irish journal of medical science. 1960;Nov(419):499-508.
dc.sourceNaguib M, Lien CA, Meistelman C. Pharmacology of neuromuscular blocking drugs. En: Miller´s Anesthesia. Eight edition. Elsevier Inc.; 2015. p. 958-94.
dc.sourceHobbiger F. The mechanism of anticurare action of certain neostigmine analogues. British journal of pharmacology and chemotherapy. 1952;7(2):223-36.
dc.sourceBom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002;41(2):266-70
dc.sourceHerring WJ, Woo T, Assaid CA, Lupinacci RJ, Lemmens HJ, Blobner M, et al. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies. Journal of Clinical Anesthesia. 2017;41:84-91.
dc.sourceDella Rocca G, Di Marco P, Beretta L. Do we need to use sugammadex at the end of general anesthesia to reverse the action of neuromuscular blocking agents? Position Paper on sugammadex use. Minerva Anestesiológica. 2013;79(6):661-6.
dc.sourcede Boer HD. Neuromuscular transmission: New concepts and agents. Journal of Critical Care. 2009;24(1):36-42.
dc.sourceHager HH, Burns B. Succinylcholine Chloride. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019. Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK499984/
dc.sourceMiller RD, Cohen NH, Eriksson LI, Fleisher LA. Miller´s Anesthesia. Eighth edi. Miller RD, editor. Philadephia, PA: Elsevier Inc.; 2015.
dc.sourceAndersson ML, Møller AM, Wildgaard K. Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review. Anaesthesia. 2019;74(4):518-28.
dc.sourceWichmann S, Færk G, Bundgaard JR, Gätke MR. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene. Pharmacogenetics and Genomics. 2016;26(7):351-6.
dc.sourceDa Silva AS, Pimentel VC, Fiorenza AM, França RT, Tonin AA, Jaques JA, et al. Activity of cholinesterases and adenosine deaminase in blood and serum of rats experimentally infected with Trypanosoma cruzi. Annals of Tropical Medicine & Parasitology. 2011;105(5):385-91.
dc.sourceGanigara A, Ravishankar C, Ramavakoda C, Nishtala M. Fatal hyperkalemia following succinylcholine administration in a child on oral propranolol. Drug Metabolism and Personalized Therapy. 2015;30(1):69-71.
dc.sourceMartyn JAJ, Richtsfeld M. Succinylcholine-induced Hyperkalemia in Acquired Pathologic States. Anesthesiology. 2006;104(1):158-69.
dc.sourceTran DTT, Newton EK, Mount V a. H, Lee JS, Mansour C, Wells GA, et al. Rocuronium vs. succinylcholine for rapid sequence intubation: a Cochrane systematic review. Anaesthesia. junio de 2017;72(6):765-77.
dc.sourceShoenberger JM, Mallon WK. Rocuronium Versus Succinylcholine Revisited: Succinylcholine Remains the Best Choice. Annals of Emergency Medicine. 2018;71(3):398-9.
dc.sourceSzakmany T, Woodhouse T. Use of cisatracurium in critical care a review of the literature. Minerva Anestesiologica. 2015;81(4):450-60.
dc.sourceLu Z, Rosenberg H, Li G. Prevalence of malignant hyperthermia diagnosis in hospital discharge records in California, Florida, New York, and Wisconsin. Journal of Clinical Anesthesia. 2017;39:10-4.
dc.sourceSebel PS, Bowdle TA, Ghoneim MM, Rampil IJ, Padilla RE, Gan TJ, et al. The incidence of awareness during anesthesia: A multicenter United States study. Anesthesia and Analgesia. 2004;99(3):833-9.
dc.sourceAytac I, Postaci A, Aytac B, Sacan O, Alay GH, Celik B, et al. Survey of postoperative residual curarization, acute respiratory events and approach of anesthesiologists. Brazilian journal of anesthesiology (Elsevier). 2016;66(1):55-62.
dc.sourceNunes RR, Porto VC, Miranda VT, De Andrade NQ, Carneiro LMM. Risk Factor for Intraoperative Awareness. Revista Brasileira de Anestesiologia. 2012;62(3):365-74.
dc.sourceSandin RH, Enlund G, Samuelsson P, Lennmarken C. Awareness during anaesthesia: a prospective case study. Lancet. 2000;355:707-11.
dc.sourceFernandez A, Frendl G, Sprung J, Kor D, Subramaniam B, Martinez R, et al. Postoperative Pulmonary Complications, Early Mortality, and Hospital Stay Following Noncardiothoracic Surgery: A Multicenter Study by the Perioperative Research Network Investigators. JAMA. 2018;152(2):157-66.
dc.sourceMiskovic A, Lumb AB. Postoperative pulmonary complications. British journal of anaesthesia. 2017;118(3):317–334.
dc.sourceToledo C, Nácul FE, Knibel MF, Silva NB, Rezende E, Grion CMC, et al. Pulmonary complications after non-cardiac surgeries: temporal patterns and risk factors. Anestezjologia Intensywna Terapia. 2014;49(4):245-51.
dc.sourceBelcher AW, Leung S, Cohen B, Yang D, Mascha EJ, Turan A, et al. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005 – 2013 : A single center study. Journal of Clinical Anesthesia. 2017;43:33-8.
dc.sourceLukannek C, Shae S, Platzbecker K, Raub D, Santer P, Nabel S, et al. The development and validation of the Score for the Prediction of Postoperative Respiratory Complications ( SPORC-2 ) to predict the requirement for early post- operative tracheal re-intubation : a hospital registry study. Anaesthesia. 2019;1-10.
dc.sourceErrando-Oyonarte CL, Moreno-Sanz C, Vila-Caral P, Ruiz de Adana-Belbel JC, Vázquez-Alonso E, Ramírez-Rodríguez JM, et al. Recomendaciones sobre el uso de bloqueo neuromuscular profundo por parte de anestesiólogos y cirujanos. Consenso AQUILES (Anestesia QUIrúrgica para Lograr Eficiencia y Seguridad). Revista Espanola de Anestesiologia y Reanimacion. 2017;64(2):95-104.
dc.sourceXará D, Santos A, Abelha F. Acontecimientos adversos respiratorios en la unidad de cuidados postanestésicos. Archivos de Bronconeumologia. 2015;51(2):69-75.
dc.sourceLedowski T, Hillyard S, O’Dea B, Archer R, Vilas FB, Kyle B. Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome. Indian Journal of Anaesthesia. 2013;57(1):46-51.
dc.sourceSchreiber J. Management of neuromuscular blockade in ambulatory patients. Current Opinion in Anaesthesiology. 2014;27(6):583-8.
dc.sourceYamamoto T, Schindler E. Where and how do anaesthetics act? Mechanisms of action in the central nervous system. Anestezjologia Intensywna Terapia. 2014;49(4):288-93.
dc.sourceZbinden AM, Petersen-Felix S, Thomson DA, Maggiorini M, Petersen-Felix S, Lauber R, et al. Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia: I. Motor reactions. Anesthesiology. 1994;80(May 2014):253-60.
dc.sourceUhrig L, Dehaene S, Jarraya B. Cerebral mechanisms of general anesthesia. Annales francaises d’anesthesie et de reanimation. 2014;33(2):72-82.
dc.sourceAlkire MT, Hudetz AG, Tononi G. Consciusness and Anesthesia. Science. 2008;7(322):876-80.
dc.sourceOsterman JE, Hopper J, Heran WJ, Keane TM, van der Kolk BA. Awareness under anesthesia and the development of posttraumatic stress disorder. General Hospital Psychiatry. 2001;23(4):198-204.
dc.sourceZhu J, Zhang X-R, Yang H. Effects of combined epidural and general anesthesia on intraoperative hemodynamic responses, postoperative cellular immunity, and prognosis in patients with gallbladder cancer. Medicine. 2017;96(10):e6137-e6137.
dc.sourceBardia A, Sood A, Mahmood F, Orhurhu V, Mueller A, Montealegre-gallegos M. Combined Epidural-General Anesthesia vs General Anesthesia Alone for Elective Abdominal Aortic Aneurysm Repair. JAMA. 2016;151(12):1116-23.
dc.sourceHemmerling T, Donati F. Neuromuscular blockade at the larynx , the diaphragm and the corrugator supercilii muscle : a review. Canadian Journal of Anesthesia. 2003;50(8):779-94.
dc.sourceSato N, Hagiwara Y, Watase H, Hasegawa K. A comparison of emergency airway management between neuromuscular blockades alone and rapid sequence intubation : an analysis of multicenter prospective study. BMC Research Notes. 2017;(January).
dc.sourceBourenne J, Hraiech S, Roch A, Gainnier M, Papazian L, Forel J-M. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome. Annals of Translational Medicine. 2017;5(14):291-291.
dc.sourceMoher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine. 2009;6(7).
dc.sourceSchulz KF, Altman DG, Moher D, Group C. & reporting CONSORT 2010 Statement : updated guidelines for reporting parallel group randomised trials. British medical journal. 2010;340(march).
dc.sourceVon Elm E, Altman DG, Pocock S, Gotzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology ( STROBE ) statement : guidelines for reporting observational studies. Brithish Medical Journal. octubre de 2007;335(7624):806 – 808.
dc.sourceStang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemology. 2010;25:603-5.
dc.sourceBlobner M, Hunter JM, Ulm K, Hollmann M. Neuromuscular monitoring and reversal: responses to the POPULAR study. The Lancet Respiratory Medicine. 2019;7:e7-8.
dc.sourceKhuri SF, Henderson WG, Depalma RG. Determinants of Long-Term Survival After Major Surgery and the Adverse Effect of Postoperative Complications. Annals of Surgery. 2005;242(3):326-43.
dc.sourceRostin P, Teja BJ, Friedrich S, Shae S, Murugappan KR, Ramachandran SK, et al. The association of early postoperative desaturation in the operating theatre with hospital discharge to a skilled nursing or long-term care facility *. Anaesthesia. 2019;(April 2018):1-11.
dc.sourceManterola C, Asenjo-lobos C, Otzen T. Jerarquización de la evidencia. Niveles de evidencia y grados de recomendación de uso actual. Revista Chilena de Infectología. 2014;31(6):705-18.
dc.sourceJammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine : European Perioperative Clinical Outcome ( EPCO ) definitions A statement from the ESA-ESICM joint taskforce on perioperative outcome meas. European Journal of Anaesthesiology. 2015;32:88-105.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectAnestesia general
dc.subjectComplicaciones postoperatorias
dc.subjectDespertar intraoperatorio
dc.subjectAnafilaxia
dc.subjectSeguridad del paciente
dc.titleEventos adversos en el perioperatorio relacionados con el uso de bloqueantes neuromusculares comparado con no utilizarlos durante la anestesia general en adultos : revisión sistemática de la literatura
dc.typemasterThesis


Este ítem pertenece a la siguiente institución